Quantum Healthcare Ltd.

As of June 30, 2026, Quantum Healthcare Ltd. carries a market capitalization of 12.59M, placing it among publicly traded companies globally. Its enterprise value stands at 15.43M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Quantum Healthcare Ltd. has 12.59B shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.78, and the price-to-book ratio stands at -6.87.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.17 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 15.43M versus a market cap of 12.59M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Quantum Healthcare Ltd. maintains a current ratio of 0.49, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -297.62, indicating conservative leverage, while an interest coverage ratio of -2.45 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -25.14, reflecting losses generated across the asset base. The company generates approximately 145,564.74 in revenue per employee across its workforce of 90.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 114.44 indicates how many times Quantum Healthcare Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Quantum Healthcare Ltd. recorded 49,000.00 in income tax expense. The company reported a pretax loss of -2.71M and -2.76M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Quantum Healthcare Ltd.'s stock has declined approximately 50.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Over the twelve months ended June 30, 2026, Quantum Healthcare Ltd. generated 13.21M in revenue and converted that into -2.76M in net income, yielding earnings per share of 0.00. EBITDA reached -731,000.00, while operating income came in at -2.44M.

As of June 30, 2026, Quantum Healthcare Ltd. holds 1.56M in cash and equivalents against 3.87M in total debt, resulting in a net debt position of -250,000.00. Total book value stands at -1.83M, with working capital of -4.94M providing operational flexibility.

Quantum Healthcare Ltd. produced 999,000.00 in operating cash flow over the twelve months ended June 30, 2026. After subtracting -58,000.00 in capital expenditures, free cash flow totaled 941,000.00 - equivalent to 0.00 per share.

Over the twelve months ended June 30, 2026, Quantum Healthcare Ltd. posted a gross margin of 44.99, reflecting its pricing power and cost economics. The operating margin of -18.49 and net profit margin of -20.91 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 9.07, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -3.27, meaning Quantum Healthcare Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Quantum Healthcare Ltd. has an Altman Z-Score of -44.25, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.